Tryngolza
Payments companies reported to CMS as associated with Tryngolza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tryngolza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tryngolza
These are the largest totals companies reported as associated with Tryngolza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Seth Baum | Boca Raton, FL | Cardiovascular Disease | $34,151.61 |
| Andres Gelrud | Miami, FL | Gastroenterology (Internal Medicine) | $19,370.92 |
| James Underberg | New York, NY | Internal Medicine | $15,925.69 |
| Jamie Dwyer | Nashville, TN | Nephrology (Internal Medicine) | $12,350.00 |
| David Davidson | Bannockburn, IL | Cardiovascular Disease | $8,658.77 |
| Joseph Witztum | San Diego, CA | Endocrinology, Diabetes & Metabolism | $7,872.00 |
| Richard Becker | Cincinnati, OH | Cardiovascular Disease | $5,900.00 |
| Alan Brown | Naperville, IL | Cardiovascular Disease | $4,585.00 |
| James Trippi | Indianapolis, IN | Cardiovascular Disease | $2,620.00 |
| Eliot Brinton | Salt Lake City, UT | Endocrinology, Diabetes & Metabolism | $2,499.27 |
Prescribed Tryngolza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.